Transitioning from NAFLD to MAFLD to MASLD in the Mexican population

Схожие документы

• Transitioning from NAFLD to MAFLD to MASLD in the Mexican population
  по: B.A. Priego-Parra, и др.
  Опубликовано: (2025-01-01)
• Ajuste de prevalencia de esteatosis hepática metabólica (MASLD) en una población mexicana
  по: R. Bernal-Reyes R, и др.
  Опубликовано: (2025-10-01)
• Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD
  по: B.A. Priego-Parra, и др.
  Опубликовано: (2024-10-01)
• Prevalence and importance of periodontal disease in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Veracruz
  по: L. Roesch-Ramos, и др.
  Опубликовано: (2026-01-01)
• Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study
  по: R. Bernal-Reyes, и др.
  Опубликовано: (2023-07-01)